Drawing for Serial No. 79330800

USPTO serial 79330800

Serial No. 79330800

Reviewed by CopyMark Law Group

Reg. 7178244Status 700Registered
Filing date
Status date
Registration date
Oct 3, 2023
Examiner
TRUSILO, KELLY JEAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 79330800?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Zaccaria

John Zaccaria Notaro, Michalos & Zaccaria P.C.100 Dutch Hill Road, Suite 240Orangeburg, NY 10962UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of infectious diseases, cardiovascular disorders, gastroenterological disorders, cognitive and neuropsychiatric disorders, blood disorders, bronchopulmonary disease, cholesterol, cardio metabolic diseases, allergies, pain, osteoarticular disorders and inflammation; medical preparations for the prevention and treatment of infectious diseases, cardiovascular disorders, gastroenterological disorders, cognitive and neuropsychiatric disorders, blood disorders, bronchopulmonary diseases, cholesterol, cardio metabolic diseases, allergies, pain, osteoarticular disorders and inflammation; veterinary substances and preparations for the prevention and treatment of infectious diseases, cardiovascular disorders, gastroenterological disorders, cognitive and neuropsychiatric disorders, blood disorders, bronchopulmonary diseases, cholesterol, cardio metabolic diseases, allergies, pain, osteoarticular disorders and inflammation; sanitary preparations for medical purposes; dietetic foods adapted for medical purposes; dietetic substances adapted for medical use; dietary supplements for veterinary purposes; dietetic foods for veterinary purposes; food for babies; medical plasters, materials for medical dressings; disinfectants; preparations for destroying noxious animals; herbicides; fungicides; nutritional supplements for veterinary purposes; dietary supplements for humans; teeth filling material; dental waxesACTIVE—
035Wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; advertising services relating to pharmaceuticals; providing business and marketing information on-line; promotion, advertising and marketing of web sites on-line; providing an on-line commercial information directory on the Internet; provision of an on-line marketplace for buyers and sellers of goods and servicesACTIVE—
041Medical training; arranging and conducting seminars and conferences in the medical field; providing child care training for non-medical staff; publication of reports featuring the result of clinical trials for pharmaceutical preparations; arranging and conducting of in-person educational forums in the fields of medicine and pharmaceuticals and the medical field; arranging and conducting in-person teaching forums in the fields of medicine and pharmaceuticals and the medical field; teaching in the field of pharmacy; adult educational services in the nature of conducting classes in the field of pharmacy; teaching in the medical fieldACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 30, 2024FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 5, 2024FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 5, 2024FIMPFINAL DISPOSITION PROCESSED—
Jan 3, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 3, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 3, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 18, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 18, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 28, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 26, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 13, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 13, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Jun 13, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 13, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 13, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 13, 2023ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jun 12, 2023ATRVATTORNEY REVIEW COMPLETED—
Jun 7, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 7, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 14, 2023PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Feb 21, 2023PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Feb 9, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 9, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Feb 9, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 9, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 9, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 27, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 27, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 27, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 27, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 27, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 27, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jan 27, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 27, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 27, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 3, 2023RFNTREFUSAL PROCESSED BY IB—
Dec 13, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 13, 2022RFRRREFUSAL PROCESSED BY MPU—
Sep 30, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 29, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 21, 2022DOCKASSIGNED TO EXAMINER—
Mar 18, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 11, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 7, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 6, 2022SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance